Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(19 sites)

United States

UCSD Altman Clinical and Translational Research Institute Building, La Jolla, California

Loma Linda University Children's Hospital - PIN, Loma Linda, California

Massachusetts General Hospital, Boston, Massachusetts

University of Texas Southwestern Medical Center, Dallas, Texas

Argentina

Hospital de Pediatría S.A.M.I.C.- Prof. Dr. Juan P. Garrahan, Parque Patricios, Ciudad Autónoma de BuenosAires

Brazil

Hospital Santa Izabel-Rua Floriano Peixoto 300, Salvador, Estado de Bahia

Hospital Sao Lucas Da Pontificia Universidade Catolica Do Rio Grande Do Sul (PUCRS), Porto Alegre/RS

CPQuali Pesquisa Clínica Sao Paulo, São Paulo

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo

Canada

Hospital For Sick Children, Toronto, Ontario

France

Centre Hospitalier Universitaire de Bicêtre, Le Kremlin-Bicêtre, Val-de-Marne

Netherlands

Erasmus MC Sophia Children's Hospital-Wytemaweg 80, Rotterdam, South Holland

Poland

Uniwersyteckie Centrum Kliniczne w Gdansku - Smoluchowskiego 17, Gdansk

Serbia

Clinic for Neurology and Psychiatry for Children and Youth, Belgrade, Belgrade

Spain

Hospital Sant Joan de Deu - PIN, Espluges de Llobregat, Barcelona

Sweden

Karolinska Universitetssjukhuset Solna, Stockholm, Stockholm County

United Kingdom

Evelina London Children's Hospital, London, London, City of

Great Ormond Street Hospital - PPDS, London, London, City of

Birmingham Women's and Children's NHS Foundation Trust, Birmingham, West Midlands